ES8706792A1 - Procedimiento de exaltacion de la fluorescencia de un ion detierra rara - Google Patents

Procedimiento de exaltacion de la fluorescencia de un ion detierra rara

Info

Publication number
ES8706792A1
ES8706792A1 ES547294A ES547294A ES8706792A1 ES 8706792 A1 ES8706792 A1 ES 8706792A1 ES 547294 A ES547294 A ES 547294A ES 547294 A ES547294 A ES 547294A ES 8706792 A1 ES8706792 A1 ES 8706792A1
Authority
ES
Spain
Prior art keywords
rare earth
application
earth metals
fluorescent labels
macropolycyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547294A
Other languages
English (en)
Other versions
ES547294A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of ES8706792A1 publication Critical patent/ES8706792A1/es
Publication of ES547294A0 publication Critical patent/ES547294A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

METODO DE EXALTACION DE LA FLUORESCENCIA DE UN ION DE TIERRA RARA. CONSISTE EN COMPLEJAR UN ION DE TIERRA RARA CON UN COMPUESTO MACROPOLICICLICO DE FORMULA (I) EN LA QUE Z ES UN ATOMO DE 3 O 4 VALENCIAS; R ES NADA O REPERESENTA H, EL GRUPO HIDROXI, UN GRUPO AMINO O UN RADICAL HIDROCARBONADO; LOS RADICALES (A), (B) Y (C), SON INDEPENDIENTEMENTE UNO DEL OTRO CADENAS HIDROCARBONADAS QUE CONTIENEN EVENTUALMENTE UNO O VARIOS HETEROATOMOS Y QUE ESTAN EVENTUALMENTE INTERRUMPIDAS POR UN HETEROMACROCICLO; Y EXCITAR EL MOTIVO DONADOR DEL COMPUESTO DE FORMULA (I). TIENEN APLICACION COMO MARCADORES EN LOS DOSIFICADOS INMUNOLOGICOS. *FORMULA*
ES547294A 1984-09-26 1985-09-25 Procedimiento de exaltacion de la fluorescencia de un ion detierra rara Expired ES8706792A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414799A FR2570703B1 (fr) 1984-09-26 1984-09-26 Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents

Publications (2)

Publication Number Publication Date
ES8706792A1 true ES8706792A1 (es) 1987-07-01
ES547294A0 ES547294A0 (es) 1987-07-01

Family

ID=9308106

Family Applications (3)

Application Number Title Priority Date Filing Date
ES547294A Expired ES8706792A1 (es) 1984-09-26 1985-09-25 Procedimiento de exaltacion de la fluorescencia de un ion detierra rara
ES557485A Expired ES8801695A1 (es) 1984-09-26 1987-04-01 Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas
ES557486A Expired ES8801938A1 (es) 1984-09-26 1987-04-01 Procedimiento para la obtencion de comopuestos macropoliciclicos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557485A Expired ES8801695A1 (es) 1984-09-26 1987-04-01 Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas
ES557486A Expired ES8801938A1 (es) 1984-09-26 1987-04-01 Procedimiento para la obtencion de comopuestos macropoliciclicos

Country Status (9)

Country Link
US (1) US4927923A (es)
EP (1) EP0180492B1 (es)
JP (3) JPH0655741B2 (es)
KR (1) KR930008210B1 (es)
AT (1) ATE90084T1 (es)
CA (1) CA1329593C (es)
DE (1) DE3587380T2 (es)
ES (3) ES8706792A1 (es)
FR (1) FR2570703B1 (es)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5220012A (en) * 1984-09-26 1993-06-15 Compagnie Oris Industrie Sa Macropolycyclic rare earth complexes and application as fluorescent tracers
SE454781B (sv) * 1986-10-17 1988-05-30 Wallac Oy Hybridiseringsforfarande for detektion av polynukleotidsekvens
FR2624862B1 (fr) * 1987-12-18 1990-06-08 Oris Ind Cryptates de terres rares, procedes d'obtention, intermediaires de synthese et application a titre de marqueurs fluorescents
US5162508A (en) * 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5134232A (en) * 1988-11-14 1992-07-28 The Regents Of The University Of California Fluorescent indicator dyes for alkali metal cations
US5094759A (en) * 1989-03-17 1992-03-10 The University Of Southern Mississippi Method of water treatment using 2,6-substituted aminopyridines and polymer derived therefrom
US5216134A (en) * 1989-10-23 1993-06-01 Wallac Oy Spectrofluorometric method and compounds that are of value for the method
FR2664699B1 (fr) * 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
EP0554358A4 (en) * 1990-09-27 1995-09-06 Brunswick Corp Chelating agents
EP0493745A1 (en) * 1990-12-21 1992-07-08 Dojindo Laboratories Fluorescent compound, complex, reagent, and specific binding assay employing said reagent
CA2072934C (en) * 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
FR2680787B1 (fr) * 1991-08-30 1994-11-04 Cis Bio Int Complexes macrocycliques de terres rares et leur utilisation pour reduire les interferences dans un dosage par fluorescence.
WO1993011433A1 (en) * 1991-12-05 1993-06-10 Wallac Oy Luminescent lanthanide chelates
US5417959A (en) * 1993-10-04 1995-05-23 Mallinckrodt Medical, Inc. Functionalized aza-crytand ligands for diagnostic imaging applications
WO1995020353A1 (en) * 1994-01-28 1995-08-03 Mallinckrodt Medical, Inc. Functionalized aza-bimacrocyclic ligands for imaging applications
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US6329139B1 (en) 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US5792330A (en) * 1995-05-31 1998-08-11 Board Of Regents, The University Of Texas System Lanthanide metal cations for concurrent detection and separation in capillary electrophoresis
FR2768817B1 (fr) * 1997-09-19 1999-12-10 Cis Bio Int Methode homogene pour la detection et/ou la determination de l'activite phosphorylante d'un materiel biologique
FR2769315B1 (fr) * 1997-10-03 2001-06-08 Cis Bio Int Conjugues fluorescents de nucleosides ou de nucleotides, leur procede de preparation et leur utilisation
EP1925320A3 (en) 1998-03-27 2008-09-03 Prolume, Ltd. Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
DE69938293T2 (de) 1998-03-27 2009-03-12 Bruce J. Beverly Hills Bryan Luciferase, gfp fluoreszenzproteine, kodierende nukleinsaüre und ihre verwendung in der diagnose
US7109315B2 (en) * 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
FR2809817B1 (fr) 2000-06-02 2003-08-15 Cis Bio Int Procede de detection de presence d'un liquide dans un melange
FR2810406B1 (fr) * 2000-06-15 2002-09-20 Cis Bio Int Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
CA2504443A1 (en) * 2002-10-30 2004-05-13 Pointilliste, Inc. Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
EP1597577A4 (en) * 2003-02-10 2007-02-21 Pointilliste Inc SELF-ARRANGING ARRAYS AND ITS APPLICATION
US7018851B2 (en) 2003-02-13 2006-03-28 Innotrac Diagnostics Oy Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
DE602004025592D1 (de) * 2003-09-12 2010-04-01 Life Technologies Corp Anwendungen des Resonanzenergietransfers zwischen Terbium und GFP
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
WO2005046735A1 (en) * 2003-11-07 2005-05-26 Newport Instruments A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
EP1778874B1 (en) * 2004-07-30 2011-11-23 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for cervical cancer
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten
JP4559922B2 (ja) * 2005-06-21 2010-10-13 株式会社東芝 蛍光性錯体及びそれを用いた照明装置
FR2890174B1 (fr) 2005-08-30 2009-04-24 Cis Bio Internat Sa Procede pour la mise en evidence d'un processus biologique par mesure d'un fret
FR2890446B1 (fr) 2005-09-05 2008-04-18 Cis Bio Internat Sa Methode de detection d'interaction intracellulaire entre bio-molecules
EP2221385A3 (en) 2005-10-28 2010-12-01 Life Technologies Corporation Deubiquination assays
US7482444B2 (en) * 2006-03-13 2009-01-27 Wallac Oy Terminating substrates for DNA polymerases
DE102006021406B4 (de) 2006-05-08 2008-08-07 B.R.A.H.M.S Aktiengesellschaft In vitro Verfahren zur Früherkennung von arznei- und suchtmittelinduzierten Leberschäden und zur Erkennung der bereits erreichten Stufe der Leberschädigung
US8216856B2 (en) 2006-08-18 2012-07-10 Abacus Diagnostica Oy Luminescent lanthanide labelling reagents and their use
US20090306368A1 (en) * 2006-11-27 2009-12-10 Sumitomo Chemical Company, Limited Polynuclear complex
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
DE102007022367A1 (de) 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
WO2010006605A2 (en) * 2008-07-16 2010-01-21 Radiometer Medical Aps Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
FR2934684B1 (fr) 2008-07-31 2012-11-16 Cis Bio Int Methode de detection de l'internalisation de proteines membranaires.
FR2936245B1 (fr) 2008-09-23 2012-07-06 Cis Bio Int Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants.
FR2940286B1 (fr) * 2008-12-19 2011-04-08 Cis Bio Int Nouveaux cryptates de terres rares comportant un motif tetraazatriphenylene
FI20090100A0 (fi) 2009-03-16 2009-03-16 Wallac Oy Biotinidaasimääritys
CN102639998B (zh) 2009-04-30 2014-12-03 Cis-生物国际公司 用于检测调节vft域膜蛋白二聚体的化合物的方法
FR2949156B1 (fr) 2009-08-13 2016-04-15 Cis-Bio Int Methode de determination de la liaison d'un compose donne a un recepteur membranaire
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
FR2978149B1 (fr) 2011-07-18 2014-01-10 Cisbio Bioassays Nouveaux agents complexants et complexes de lanthanide correspondant, et leur utilisation comme marqueurs luminescents
FR2980271B1 (fr) 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
WO2013042120A2 (en) 2011-09-19 2013-03-28 Proteologics Ltd Synthetic ubiquitins and use thereof in drug screening assays
US20150185150A1 (en) 2012-02-22 2015-07-02 Cisbio Bioassays Method for normalizing the luminescence emitted by a measuring medium
FR2988174B1 (fr) 2012-03-19 2014-04-25 Cisbio Bioassays Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
WO2014136115A1 (en) 2013-03-07 2014-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Non-selfabsorbing luminescent solar concentrator
FR3004189B1 (fr) 2013-04-04 2015-09-04 Ecole Norm Superieure Lyon Complexes de lanthanide comprenant au moins deux groupes betaines, utiles comme marqueurs luminescents
FR3032797B1 (fr) 2015-02-13 2017-03-03 Cisbio Bioassays Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
JP6944449B2 (ja) 2015-11-27 2021-10-06 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 対象の細胞外液量状態のマーカーとしてのＭＲ−ｐｒｏＡＤＭ
FR3045053B1 (fr) 2015-12-09 2018-01-05 Cisbio Bioassays Agents complexants hydrosolubles a base de triazapyridinophane et complexes de lanthanide fluorescents correspondants
JP7046833B2 (ja) 2016-01-21 2022-04-04 セルックス・ダイアグノスティクス・インコーポレイテッド 迅速な抗菌剤感受性試験のための方法
US9834808B2 (en) 2016-01-21 2017-12-05 SeLux Diagnostics, Inc. Methods for rapid antibiotic susceptibility testing
US20190178894A1 (en) 2016-08-09 2019-06-13 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating an adverse event
JP7194673B2 (ja) 2016-08-09 2022-12-22 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 臓器障害を示すマーカーとしてのヒストンおよび／またはｐｒｏＡＤＭ
EP3555127A1 (en) 2016-12-16 2019-10-23 H. Lundbeck A/S Agents, uses and methods
EP3559252A1 (en) 2016-12-23 2019-10-30 Selux Diagnostics, Inc. Methods for improved rapid antimicrobial susceptibility testing
EP4220175A1 (en) 2017-02-02 2023-08-02 B.R.A.H.M.S GmbH Proadm as marker indicating an adverse event
US20200225248A1 (en) 2017-05-31 2020-07-16 B.R.A.H.M.S Gmbh Mmp-8 as a marker for identifying infectious disease
FR3067349B1 (fr) 2017-06-12 2020-12-04 Cisbio Bioassays Nouveaux agents mono et di-antennes complexants hydrosolubles et complexes de lanthanide correspondants
FR3067712B1 (fr) 2017-06-14 2019-08-02 Cisbio Bioassays Nouveaux agents complexants de type trimethoxyphenyl pyridine hydrosolubles et complexes de lanthanide correspondants
FR3069644B1 (fr) 2017-07-28 2024-07-12 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
CA3075442C (en) 2017-09-13 2024-04-02 B.R.A.H.M.S Gmbh Pct and pro-adm as markers for monitoring antibiotic treatment
JP7329503B2 (ja) 2017-09-13 2023-08-18 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 重篤患者用の療法モニタリングマーカーとしてのｐｒｏ－ａｄｍ
JP7346389B2 (ja) 2017-09-13 2023-09-19 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 異常な血小板レベルのマーカーとしてのプロアドレノメジュリン
EP3502691A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Proadrenomedullin as indicator for renal replacement therapy in critically ill patients
WO2019053124A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh PROADRENOMEDULINE AS AN INDICATOR FOR RENAL REPLACEMENT THERAPY IN SERIOUSLY PATIENT PATIENTS
EP3729083A1 (en) 2017-12-20 2020-10-28 B.R.A.H.M.S GmbH Antibiotic therapy guidance based on pro-adm
WO2019122088A1 (en) 2017-12-20 2019-06-27 B.R.A.H.M.S Gmbh Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
WO2019121952A1 (en) 2017-12-21 2019-06-27 H. Lundbeck A/S Assay, method and treatment of alpha-synucleinopathies
EP3578989A1 (en) 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3084365B1 (fr) 2018-07-27 2020-10-23 Cisbio Bioassays Anticorps a domaine unique qui se lient a la proteine g alpha
EP3608673A1 (en) 2018-08-08 2020-02-12 B.R.A.H.M.S GmbH Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease
EP3918343A1 (en) 2019-01-28 2021-12-08 B.R.A.H.M.S GmbH Method to predict treatment response in patients with nocturnal enuresis
FR3092172B1 (fr) 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
CN113424065A (zh) 2019-02-21 2021-09-21 B.R.A.H.M.S有限公司 对手术后不良事件进行的诊断或预后
EP3715851A1 (en) 2019-03-29 2020-09-30 B.R.A.H.M.S GmbH Prescription of remote patient management based on biomarkers
AU2020253042A1 (en) 2019-03-29 2021-06-17 B.R.A.H.M.S Gmbh Prescription of remote patient management based on biomarkers
EP4022079A4 (en) 2019-08-27 2024-07-03 Selux Diagnostics Inc SYSTEMS AND METHODS FOR CONDUCT ANTIMICROBIAL SUSCEPTIBILITY TEST
CA3168893A1 (en) 2020-04-06 2021-10-14 Stefan EBMEYER Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (sars)
CN115136009A (zh) 2020-04-09 2022-09-30 B.R.A.H.M.S有限公司 用于呼吸道感染诊断的生物标志物
AU2022405688A1 (en) 2021-12-08 2024-06-06 B.R.A.H.M.S Gmbh Biomarkers for prognosis of early onset preeclampsia
CA3240914A1 (en) 2021-12-13 2023-06-22 Universite Laval Biomarkers for the prediction of preterm birth
WO2024121392A1 (en) 2022-12-08 2024-06-13 B.R.A.H.M.S Gmbh Multiple sflt-1 measurements for prognosis of early onset preeclampsia

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888877A (en) * 1969-06-11 1975-06-10 Schering Corp Macrocyclic compounds and complexes thereof
US3847949A (en) * 1970-05-12 1974-11-12 Du Pont Macrocyclic hetero imine complexing agents
CA966127A (en) * 1970-05-12 1975-04-15 Marilyn H. Bromels Macrocyclic hetero imine complexing agents
US4156683A (en) * 1973-03-26 1979-05-29 Schering Corporation Complexes of macrocyclic compounds
US3966766A (en) * 1973-03-26 1976-06-29 Schering Corporation Monocyclic macrocyclic compounds and complexes thereof
US4058732A (en) * 1975-06-30 1977-11-15 Analytical Radiation Corporation Method and apparatus for improved analytical fluorescent spectroscopy
SE428332B (sv) * 1979-03-08 1983-06-20 Wallac Oy Forfarande for fluorescensspektroskopisk bestemning av biologiskt aktivt emne, sasom hapten, antikropp eller antigen
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
CA1205028A (en) * 1981-07-01 1986-05-27 Jerald C. Hinshaw Fluorescent chelates and labeled specific binding reagents prepared therefrom
DE3202779A1 (de) * 1982-01-28 1983-08-04 Merck Patent Gmbh, 6100 Darmstadt Kaliumreagens und verfahren zur bestimmung von kaliumionen
US4631119A (en) * 1983-11-23 1986-12-23 W. R. Grace & Co. Reversible, electrochemically-switched lariat ethers
US4734376A (en) * 1985-02-04 1988-03-29 The President & Trustees Of The Miami University Process for the spectrophotometric measurement of lithium ion employing a chromogenic aza-12-crown-4- ether
US4659815A (en) * 1985-02-04 1987-04-21 The President And Trustees Of The Miami University Chromogenic aza-12-crown-4 ethers and method of using same for the detection of lithium
GB8528804D0 (en) * 1985-11-22 1985-12-24 Amersham Int Plc Compounds

Also Published As

Publication number Publication date
ES8801695A1 (es) 1988-02-16
JPH06184151A (ja) 1994-07-05
EP0180492A1 (fr) 1986-05-07
DE3587380D1 (es) 1993-07-08
CA1329593C (en) 1994-05-17
JPH0714935B2 (ja) 1995-02-22
ES557486A0 (es) 1988-03-01
FR2570703A1 (fr) 1986-03-28
FR2570703B1 (fr) 1988-07-08
JPH0655741B2 (ja) 1994-07-27
ES557485A0 (es) 1988-02-16
KR860002553A (ko) 1986-04-26
ES547294A0 (es) 1987-07-01
JPS6187680A (ja) 1986-05-06
JPH06199858A (ja) 1994-07-19
JPH0715471B2 (ja) 1995-02-22
DE3587380T2 (de) 1994-01-05
ATE90084T1 (de) 1993-06-15
KR930008210B1 (ko) 1993-08-26
EP0180492B1 (fr) 1993-06-02
US4927923A (en) 1990-05-22
ES8801938A1 (es) 1988-03-01

Similar Documents

Publication Publication Date Title
ES8801695A1 (es) Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas
ES8305761A1 (es) Un procediemiento para la preparacion de lactamas biciclicas.
ES2019942B3 (es) Tratamiento de formaciones subterraneas que contienen hierro.
UA39174C2 (uk) Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції
BG103170A (en) Polymorphic form ii of finasteride and method for its preparation
IT1183757B (it) Procedimento per la frantumazione di giacimenti sotterranei di carbone
EP0151036A3 (en) N.m.r. shims
BG101892A (en) Sugar-modified cytostatics
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
NO864106D0 (no) Fremgangsmaate til fremstilling av legeringer av sjeldne jordmetaller og jern.
HU9500559D0 (en) New mercapto-acetamide tricyclic derivatives as enkephalinase-inhibitors
DE3565707D1 (en) Compositions and methods for reducing the permeability of underground strata
DE3576680D1 (de) Rueckgewinnung von metallen.
ES8707253A1 (es) Procedimiento para preparar sialosilcerebrosido gm4
IT8026415A0 (it) Arco particolarmente per l'impiego nel rivestimento di gallerie come ad esempio gallerie di miniere sotterranee.
ES2001247A6 (es) Un procedimiento para la preparacion de un derivado de gem-dihalo o tetrahalo-1,12-diamino-4,9-diaza-dodecano.
ES8507530A1 (es) Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas.
CA1264325C (en) AROYLIMIDAZOLONES
HUT41451A (en) Activator for increasing the strength of iron-based alloy systems
SU1090060A1 (ru) Способ разработки нефтяной залежи
SU1256381A1 (ru) Способ переработки редкоземельного концентрата
SU1271111A1 (ru) Сплав на основе алюминия
SU928823A1 (ru) Сплав на основе алюминия
SU1258083A1 (ru) Сталь
JO1398B1 (en) New vehicles

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070514